
MAC Clinical Research celebrates MHRA Approval for Phase I MAD Study of KP405 in Collaboration with Kariya Pharmaceuticals
MAC Clinical Research is delighted to announce that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved amendments